The key finding
A 2025 review of studies examining the gut microbiome in anxiety disorders found that certain bacterial groups—including Eubacterium, Coprococcus, and Faecalibacterium—appear to be depleted in people with generalized anxiety disorder (GAD). While most existing studies are small and observational, preliminary evidence also suggests that probiotic supplements may be linked to reduced anxiety symptoms, though most trials have been conducted in people without diagnosed anxiety disorders rather than clinical populations. Research on panic disorder and social anxiety disorder remains scarce, and no studies have yet examined the microbiome in agoraphobia.
What the study looked like
This was a comprehensive review paper that surveyed existing research on the gut microbiome across four major anxiety disorders: generalized anxiety disorder, panic disorder, agoraphobia, and social anxiety disorder. The authors examined studies that analyzed the composition and function of gut bacteria in people with these conditions, as well as trials testing microbiome-based interventions like probiotics. Most of the underlying studies they reviewed were cross-sectional designs—meaning they captured a snapshot in time rather than following people over months or years. The studies typically compared stool samples or microbiome profiles between people with diagnosed anxiety disorders and healthy control groups, looking for differences in bacterial diversity and specific microbial taxa.
Why researchers think this happened
The authors point to the emerging concept of the microbiome-gut-brain axis—a bidirectional communication system linking gut bacteria to brain function. Specific bacterial groups that appear depleted in GAD, such as Faecalibacterium, are known to produce short-chain fatty acids, which have anti-inflammatory properties and may influence neurotransmitter production. The gut microbiome can affect the nervous system through multiple pathways: by producing neuroactive compounds, modulating immune responses, and influencing the vagus nerve that connects the gut to the brain. The review notes that while correlation patterns are emerging across multiple small studies, the field hasn’t yet established whether microbiome changes cause anxiety, result from anxiety, or both. The limited research on panic disorder and social anxiety disorder may reflect the historical focus on GAD in microbiome research, or differences in how these conditions manifest physiologically.
How to read this carefully
The authors emphasize that nearly all existing studies are small and cross-sectional, making it impossible to determine causality. A depleted bacterial population might contribute to anxiety, but anxiety itself—along with associated behaviors like altered eating patterns, sleep disruption, or medication use—could also change gut bacteria. The review notes that probiotic studies showing benefits have mostly involved non-clinical populations rather than people diagnosed with anxiety disorders, limiting applicability. Geographic and dietary differences between study populations may also affect results, as microbiome composition varies widely across cultures. The lack of research in some anxiety subtypes means findings cannot be generalized across all anxiety conditions. Replication in larger, longitudinal studies tracking people over time is needed before drawing firm conclusions.
What this means for everyday life
This research adds to growing evidence that gut health and mental health may be interconnected, though we’re still in early stages of understanding how. Given these associations, it might be worth considering gut-supporting habits—like eating diverse fiber-rich foods that feed beneficial bacteria—as part of an overall approach to wellbeing, alongside established anxiety treatments. If you’re experiencing anxiety symptoms, this review suggests that conventional treatments remain the evidence-based first line, while probiotic supplements show preliminary but not yet definitive benefits. The findings also highlight why discussing digestive health with mental health providers could become increasingly relevant as this field develops. Future clinical trials may eventually clarify whether targeted microbiome interventions can meaningfully support anxiety treatment.